QQ客服 官方微博 反馈留言

	Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy
	Jiang, J.; Zhang, Y.; Peng, K.; Wang, Q.; Hong, X.; Li, H.; Fan, G.; Zhang, Z.; Gong, T.; Sun, X.
刊名	Acta Biomaterialia
	2017
卷号	Vol.61页码:114-123
关键词	Adenovirus Cancer immunotherapy Interleukin-12 Melanoma Transforming growth factor-β β-Cyclodextrin-PEI
ISSN号	1742-7061
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1822104
专题	四川大学
作者单位	Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China
推荐引用方式 GB/T 7714	Jiang, J.,Zhang, Y.,Peng, K.,et al. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy[J]. Acta Biomaterialia,2017,Vol.61:114-123.
APA	Jiang, J..,Zhang, Y..,Peng, K..,Wang, Q..,Hong, X..,...&Sun, X..(2017).Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.Acta Biomaterialia,Vol.61,114-123.
MLA	Jiang, J.,et al."Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy".Acta Biomaterialia Vol.61(2017):114-123.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。